The trademark application EXKALBRI was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). Application filed.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations and substances for the treatment of cardiovascular, metabolic, and renal diseases and disorders.